EGFR and large cell carcinoma: Lysates from eight EGFR-mutant, four KRAS-mutant, and two EGFR/KRAS wild-type LUAD, as well as two large cell carcinoma and four SCLC cell lines were assessed (Figure 1—figure supplement 1a).